SEC Form 4 · accession 0001289340-18-000013
Stereotaxis, Inc. · STXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred A Middleton
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 2, 2018 · 2:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001289340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2018 | A | 30,000 | $0.00 | A | 149,682 | D | |
| Common Stock | holding | — | — | — | 1,107,189 | I | Sanderling Venture Partners VI Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 6,358 | I | Sanderling VI Limited Partnership | |
| Common Stock | holding | — | — | — | 5,335 | I | Sanderling VI Beteiligungs GmbH & Co. KG | |
| Common Stock | holding | — | — | — | 53,275 | I | Sanderling IV Biomedical Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 11,097 | I | Sanderling V Beteiligungs GmbH & Co. KG | |
| Common Stock | holding | — | — | — | 39,716 | I | Sanderling V Biomedical Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 11,956 | I | Sanderling V Limited Partnership | |
| Common Stock | holding | — | — | — | 67,790 | I | Sanderling Venture Partners V Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 22,451 | I | Sanderling Venture Partners IV Co-Investment Fund |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest immediately upon the date of the grant.